Influence of blood storage and sample processing on molecular detection of circulating prostate cells in cancer

Clinical Chemistry

Volumn 44, Issue 3, 1998, Pages 677-679

  Berteau, Pierre ^a   Dumas, Frédéric ^a   Gala, Jean Luc ^b   Eschwège, Pascal ^c   Lacour, Bernard ^a   Philippe, Marianne ^b   Loric, Sylvain ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^c BICÊTRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ACCURACY; ANTIGEN DETECTION; ARTICLE; BLOOD SAMPLING; BLOOD STORAGE; HUMAN; PROTEIN BLOOD LEVEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0031886842     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/44.3.677     Document Type: Article

References (10)

1. Pelkey TJ, Frierson HF Jr, Bruns DE. Molecular and immunological detection of circulating tumor cells and micrometastases from solid tumors. Clin Chem 1996;42:1369-81.
2. Ennis RD, Katz AE, De Vries GM, Heitjan DF, O'Toole KM, Rubin M, et al. Detection of circulating prostate carcinoma cells via an enhanced reverse transcriptase-polymerase chain reaction assay in patients with early stage prostate carcinoma. Cancer 1997;79:2402-8.
3. Deguchi T, Doi T, Ehara H, Ito S, Yoshinori Y, Nishino Y, et al. Detection of micrometastatic prostate cancer cells in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res 1993;53:5350-4.
4. Wood DPJ, Banks ER, Humphreys S, Rangnekar VM. Sensitivity of immunechemistry and polymerase chain reaction in detecting prostate cancer cells in bone marrow. J Histochem Cytochem 1994;42:505-11.
5. Israeli RS, Miller WH Jr, Su SL, Powell CT, Fair WR, Samadi DS, et al. Sensitive nested reverse transcriptase-polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate specific membrane antigen and prostate specific antigen based assays. Cancer Res 1994;54:6306-10.
6. Cama C, Olsson CA, Raffo AJ, Perlman H, Buttyan R, O'Toole K, et al. Molecular staging of prostate cancer II. A comparison of the application of an enhanced reverse transcriptase-polymerase chain reaction assay for prostate specific antigen versus prostate specific membrane antigen. J Urol 1995;153:1373-8.
7. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, et al. LNCaP model of human prostatic carcinoma. Cancer Res 1983;43:1809-18.
8. Chomczynski P, Sacchi N. Single-step method of RNA-isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156-69.
9. Loric S, Dumas F, Eschwege P, Blanchet P, Benoit G, Jardin A, Lacour B. Enhanced detection of hematogenous circulating prostatic cells in patients with prostate adenocarcinoma using prostate-specific membrane antigen (PSM)-based nested reverse transcription-polymerase chain reaction assay. Clin Chem 1995;41:1698-704.
10. Matsumura M, Niwa Y, Kato N, Komatsu Y, Shiina S, Kawabe T. Detection of alpha-protein mRNA, an indicator of hematogenous spreading hepatocellular carcinoma in the circulation: a possible predictor of metastatic hepatocellular carcinoma. Hepatology 1994;20:1418-25.